School of Medicine
Showing 1-10 of 48 Results
-
Randall Vagelos, MD
Professor of Medicine (Cardiovascular)
Current Research and Scholarly InterestsI. Congestive Heart Failure New Medical Therapies Prognostic Evaluation Selection for Cardiac Transplantation II. Screening for Myocardial Necrosis New ECG Monitoring Devices New Serum Markers III. Screening for CAD Patients Who Have Received Radiation Rx Diabetics Being Considered for Renal Transplantation
IV. Advanced coronary and valvular disease, evaluationg candidacy for high risk interventions. -
Sharif Vakili, MD, MBA, MS
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioSharif Vakili, MD, MBA, MS, (pronouns: he/him), is an internal medicine physician and educator. He practices at Stanford Los Altos Primary Care.
Dr. Vakili has a background in chronic disease management and health systems delivery, believing strongly in a teamwork approach to patient care that empowers patients to navigate the health system as part of their clinical care.
He is active in the research and business communities. His research has been in peer-reviewed journals including JAMA Network Open, the Annals of Emergency Medicine, Quality Management in Healthcare, and Journal of Clinical Rheumatology.
Dr. Vakili is also the inventor of Remote Patient Intervention (RPI), a model of clinician-supervised AI care delivery first performed at Stanford during a clinical study published in JAMA Network Open. -
Hannah Valantine
Professor of Medicine (Cardiovascular)
On Leave from 09/01/2024 To 08/31/2025Current Research and Scholarly InterestsMy lab is focused on understanding the mechanism mediating acute and chronic allograft failure, in particular on the role of microvascular injury in acute allograft failure and the mechanisms of mediating transplant coronary artery disease. 1. Role of microvascular injury in acute allograft failure.
-
Laurent D Valosek
Academic Staff - Hourly - CSL, Medicine
BioMr. Valosek has 35 years of experience as an entrepreneur, educator and researcher. He was co-founder and CEO of Integrated Devices LLC, a wireless engineering consulting firm, Xistor Technology Development Corporation, a semiconductor intellectual property company, and Sophia Communications, a wireless technology development and wide area network service provider. He also co-founded a strategy and business development consulting firm, Lakshmi Technologies, with partners from the Boston Consulting Group and Deloitte, focused on providing services to early stage high technology companies. Mr. Valosek has extensive experience in the areas of strategy, planning, recruiting, training, business development and general management.
In addition to his business expertise, Mr. Valosek has a long standing interest in the role of human development as it relates to health, education, organizational effectiveness and social transformation. He helped conduct NIH-funded research on meditation and heart health at the West Oakland Health Center and ADHD research with middle school students in the Albany Unified School District. He co-founded the Center for Wellness and Achievement in Education in 2007, for the purpose of providing evidence-based wellness programs to students, schools, school districts and other community organizations. -
Laura van Dam
Postdoctoral Scholar, Immunology and Rheumatology
BioI am both trained as a biomedical researcher and medical doctor in internal medicine and strive to close the gap between the clinic and fundamental sciences with translational research. My focus is to study the mechanisms of autoimmune diseases and to translate research insights into therapeutics targeting autoimmunity. I have received my PhD in 2022 in Leiden for studying neutrophil extracellular traps and autoreactive B cells in renal autoimmune diseases. My postdoctoral research project in the Robinson lab focuses on investigating the underlying molecular mechanisms of the pathogenesis of ANCA-associated vasculitis. I particularly aim to identify potential microbial triggers and molecular mimicry in ANCA-associated vasculitis, by characterizing the nasal microbiome and sequencing T cells and B cells of ANCA-associated vasculitis patients.
